Decellularized, xenogeneic small-diameter arteries: transition from a muscular to an elastic phenotype in vivo

J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):95-104. doi: 10.1002/jbm.b.31074.

Abstract

Reports regarding the biocompatibility of xenogeneic, decellularized bioprosthetic implants differ between bioinertness and complete graft degradation. We investigated heparin-crosslinked and nonheparinized, xenogeneic vascular substitutes in a rat model. Porcine arteries (15 x 1.5 mm) were decellularized by multistep detergent and enzymatic techniques, which were followed by heparin-crosslinking in 50% of the implants. Prostheses were implanted into the abdominal aorta of 76 rats for 1 day and up to 6 months. Retrieved specimens were evaluated by histology, immunohistochemistry, laser scanning, and scanning electron microscopy. Graft patency did not differ between groups (97.3%). Heparinized grafts showed a statistically significant lower rate of aneurysm formation (p = 0.04 %). Implants revealed infiltration with granulocytes and macrophages up to 3 months. Recellularization with endothelial cells and myofibroblasts was detectable within 1 month. After 6 months elastin biosynthesis and complete graft remodeling toward an elastic vessel was evident. These results indicate that temporary inflammation does not interfere with long-term vascular remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aneurysm / etiology
  • Animals
  • Aorta, Abdominal / surgery
  • Arteries / surgery
  • Arteries / transplantation*
  • Blood Vessel Prosthesis* / adverse effects
  • Cross-Linking Reagents
  • Elasticity
  • Endothelial Cells / cytology
  • Fibroblasts / cytology
  • Granulocytes / pathology
  • Heparin
  • Inflammation / pathology
  • Macrophages / pathology
  • Materials Testing
  • Phenotype
  • Rats
  • Swine
  • Transplantation, Heterologous / adverse effects
  • Transplantation, Heterologous / methods*
  • Vascular Patency

Substances

  • Cross-Linking Reagents
  • Heparin